Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Case Reports in Transplantation|January 19, 2017
Urinary Obstruction of Transplanted Kidney Caused by Uterine Adenomyosis and 2-Year Posthysterectomy Psoas Abscess in Conjunction with Transplanted KidneyYuta Takezawa, Yoshifumi Kadono, Takahiro Nohara, et al.
Molecular and Clinical Oncology|September 13, 2017
Metanephric adenoma treated with laparoscopic nephrectomy: A case reportYuta Takezawa, Kouji Izumi, Hiroko Ikeda, et al.
Urology|April 13, 2015
Chronological Urodynamic Evaluation of Changing Bladder and Urethral Functions After Robot-assisted Radical ProstatectomyYoshifumi Kadono, Satoru Ueno, Daiki Iwamoto, et al.
Anticancer Research|November 1, 2016
Metastasectomy Improves Survival in Patients with Metastatic Urothelial CarcinomaHiroaki Iwamoto, Kouji Izumi, Yusuke Shimura, et al.
Molecular and Clinical Oncology|February 19, 2021
Durable response achieved using Pazopanib for germ tumor cells: A case reportYuta Takezawa, Hiroshi Yaegashi, Masashi Iijima, et al.
In Vivo (Athens, Greece)|April 28, 2019
Effectiveness of Synthetic Polymer-coated Peripherally Inserted Central Catheter in Patients With Advanced CancerYuta Takezawa, Kouji Izumi, Taiki Kamijima, et al.
Anticancer Research|July 31, 2020
Comparison of Tolerability Between 2-Weekly and 3-Weekly Docetaxel Regimen in Castration-resistant Prostate CancerYusuke Shimura, Yukio Suga, Shingo Itai, et al.
Neurourology and Urodynamics|September 10, 2015
Use of preoperative factors including urodynamic evaluations and nerve-sparing status for predicting urinary continence recovery after robot-assisted radical prostatectomy: Nerve-sparing technique contributes to the reduction of postprostatectomy incontinenceYoshifumi Kadono, Satoru Ueno, Suguru Kadomoto, et al.
Anticancer Research|March 31, 2018
Crosstalk Between Androgen-sensitive and Androgen-insensitive Prostate Cancer CellsYuta Takezawa, Kouji Izumi, Kazuaki Machioka, et al.
Anticancer Research|September 16, 2016
Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell CarcinomaYuta Takezawa, Kouji Izumi, Yusuke Shimura, et al.
Pageof 2